Trials / Sponsors / Pierian Biosciences
Pierian Biosciences
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patie Ovarian Cancer | — | 2023-11-22 |
| Withdrawn | Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (Correct Cancer | — | 2014-04-01 |
| Terminated | Validation of the MiCK Assay Mesothelioma, Small Cell Lung Cancer, NSCLC | — | 2012-06-01 |
| Completed | Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients Cancer | — | 2008-12-01 |
| Completed | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms | Phase 2 / Phase 3 | 2006-09-01 |
| Completed | Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas Adenocarcinoma, Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 2 / Phase 3 | 2006-03-01 |
| Completed | Use of the MiCK Assay for Apoptosis in AML Leukemia, Myelocytic, Acute | — | 2006-01-01 |